Skip to main content

Gilead's latest deal aims to spread Covid-fighting drug globally

The deals — royalty free for now — come as Gilead faces pricing pressure at home and competition from rogue remdesivir manufacturers overseas.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.